Open Access<p>Long-Term Results of Concurrent Chemoradiotherapy Combined with Anti-EGFR Monoclonal Antibody Prior to Surgery in Locally Advanced Cervical Cancer: A Single-Institute Prospective Study</p>
Author(s) -
Defeng Qing,
Yuying Wu,
Xu Liu,
Haijun Jiang,
Chaosheng Zhu,
Pei Liu,
Junming Dang,
Xianglong Li,
Zhaohong Chen,
Xianfeng Long,
Qiang Pang,
Luxing Peng,
Shan Deng,
Jingmin Gu,
Ren Zhao,
Changyi Chen,
Hongsheng Lu
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s282372
Subject(s) - nimotuzumab , medicine , nedaplatin , cervical cancer , chemoradiotherapy , radical surgery , radical hysterectomy , surgery , lymphadenectomy , oncology , stage (stratigraphy) , radiation therapy , hazard ratio , urology , cancer , chemotherapy , cisplatin , epidermal growth factor receptor , confidence interval , paleontology , biology
We aimed to evaluate the long-term survival outcomes of concurrent chemoradiotherapy (CCRT) combined with nimotuzumab followed by surgery in patients with locally advanced cervical cancer (LACC).